Ignite Creation Date:
2024-05-06 @ 5:51 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05456256
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2022-07-06
Brief Title:
A Study of LP-300 with Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma
Sponsor:
Lantern Pharma Inc
Organization:
Lantern Pharma Inc
Organization Data
Organization:
Lantern Pharma Inc
Class:
INDUSTRY
Study ID:
LTRN300-2LC01-OR21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lantern Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None